Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $5.9300 (-4.89%) ($5.9300 - $5.9300) on Fri. Dec. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.27% (three month average) | RSI | 65 | Latest Price | $5.9300(-4.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -1.7% a day on average for past five trading days. | Weekly Trend | CEMI advances 7.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) VIXM(40%) VXX(34%) OIH(-0%) EWY(-7%) EDOC(34%) | Factors Impacting CEMI price | CEMI will decline at least -2.635% in a week (0% probabilities). XHB(-75%) LQD(-75%) SPY(-71%) XLK(-66%) PCY(-65%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.635% (StdDev 5.27%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $6.28(-5.57%) | 10 Day Moving Average | $6.46(-8.2%) | 20 Day Moving Average | $5.77(2.77%) | To recent high | -21.4% | To recent low | 18.6% | Market Cap | $120m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |